List view / Grid view
18 September 2018 | By Clarivate Analytics
In 2017 the WHO estimated that the counterfeit drug market represents around 10-15 percent of the pharmaceutical market worldwide, with an estimated $200bn revenue per year. Worldwide there were 3,509 pharmaceutical crime incidents in 2017, which represents an 11% increase from 2016. Most falsified medicines that reach the market do…
Maintaining public confidence in the use of Big Data for health research is essential, according to international researchers.
The FDA has approved Ogivri as a biosimilar to Herceptin for the treatment of patients with breast or metastatic stomach cancer whose tumours overexpress the HER2 gene...
The Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), Mike Thompson responds to the UK’s Budget announcement...
Corporate codes of ethics can have reverse effects and mask anomalies or social evils in operations outsourced to low-wage countries...
The ABPI has responded to a joint letter from Jeremy Hunt, Secretary of State for Health, and Greg Clark, Secretary of State for Business, published by the Financial Times, that outlined the UK Government’s plans for the regulation of medicines as the UK leaves the European Union (EU).
The European Medicines Agency (EMA) has published an action plan that aims to foster innovation and support small and medium-sized enterprises (SMEs) in the development of novel human and veterinary medicines.
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
6 November 2015 | By Ashley Puscas, Associate Attorney at Laura Devine Attorneys
In our globalised economy, it is more common than ever to see pharma companies expanding to establish a presence in multiple markets. Here Ashley Puscas discusses the immigration pathways for pharma seeking to relocate or expand in the US...
Can purchased or free scientific content be reused or shared? Not necessarily, as the free white paper from RightsDirect explains...
13 May 2011 | By European Pharmaceutical Review
Pfizer will settle more than 2,200 lawsuits alleging the company's Wyeth unit hid Prempro's cancer risks...
19 April 2011 | By Jim Kinnier Wilson, Partner, Manches
Imagine that you are part of a small biotech company, BiotechCo, whose business is the development of delivery systems for pharmaceutical products. One of your team, who is in charge of developing sales with a large pharmaceutical company, Pharma Co, came to you three months ago with the possibility of…
18 January 2011 | By GlaxoSmithKline (GSK)
GSK expects to record a legal charge for the fourth quarter of 2010 of £2.2 billion ($3.4 billion)...
